Arteris, Inc.

Informe acción NasdaqGM:AIP

Capitalización de mercado: US$1.6b

Arteris Crecimiento futuro

Future controles de criterios 2/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Arteris de 59.3% y 23.2% respectivamente, mientras que el BPA crecerá en un 61% al año.

Información clave

59.3%

Tasa de crecimiento de los beneficios

60.97%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Software19.9%
Tasa de crecimiento de los ingresos23.2%
Rentabilidad financiera futuran/a
Cobertura de analistas

Low

Última actualización13 May 2026

Actualizaciones recientes sobre el crecimiento futuro

Artículo de análisis Nov 07

Arteris, Inc. (NASDAQ:AIP) Analysts Are Pretty Bullish On The Stock After Recent Results

Shareholders of Arteris, Inc. ( NASDAQ:AIP ) will be pleased this week, given that the stock price is up 12% to...
Artículo de análisis May 15

Arteris, Inc. (NASDAQ:AIP) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Investors in Arteris, Inc. ( NASDAQ:AIP ) had a good week, as its shares rose 3.7% to close at US$7.51 following the...

Recent updates

Seeking Alpha Jun 06

Arteris: A Hidden Beneficiary Of Hyperscaler AI Spending

Summary Arteris is uniquely positioned in the semiconductor value chain, supplying NoC interconnect IP critical for AI-driven SoC development. I initiate coverage with a buy rating and a $41 price target, reflecting over 11% upside, supported by robust AI infrastructure demand and raised FY 2026 revenue guidance. AIP's Q1 2026 revenue grew 39% YoY, with strong RPO and positive FY 2026 FCF guidance, though GAAP profitability remains elusive due to acquisition-related costs. Cycuity's acquisition expands AIP's reach into cybersecurity-sensitive verticals like aerospace and defense, but integration and execution risks warrant close monitoring. Read the full article on Seeking Alpha
Actualización de narrativa Jun 05

AIP: Data Center AI Royalties Will Test Elevated Multiple And Margin Discipline

Analysts have lifted their average price target on Arteris from $20 to a range of $35 to $40. They cite a recent beat and raise quarter, stronger data center and AI related licensing activity, and expectations for earlier and higher royalty contributions compared with automotive licenses.
Actualización de narrativa May 20

AIP: AI Licensing Momentum Will Test Elevated Multiple And Margin Discipline

Narrative Update: Arteris Analyst Price Target Reset The analyst fair value estimate for Arteris has moved from $16.00 to $35.00, reflecting higher Street price targets in the $35 to $40 range. Analysts attribute this change to what they describe as a "beat and raise" quarter, stronger data center and AI related licensing momentum, and improved royalty trends supported by earlier royalty revenue timing and higher average selling prices.
Actualización de narrativa May 04

AIP: Elevated Future P/E Assumptions Will Likely Constrain Forward Return Potential

Analysts have increased their price target on Arteris by $0.25 to $20.50 as they refresh their assumptions around the discount rate, profit margin, revenue growth and future P/E expectations. Analyst Commentary Bullish Takeaways Bullish analysts view the refreshed assumptions on discount rate, profit margin, revenue growth and future P/E expectations as supportive of a higher valuation ceiling, which is reflected in the recent price target updates.
Actualización de narrativa Apr 23

Arteris Inc. – Collaboration with MIPS to Accelerate Physical AI SoC Platforms

Arteris Inc. has announced a strategic collaboration with MIPS, a subsidiary of GlobalFoundries, to accelerate the development of next-generation system-on-chip (SoC) platforms tailored for physical AI applications.
Actualización de narrativa Apr 19

AIP: Elevated Multiple And Margin Uncertainty Will Constrain AI Era Upside

Analysts have raised their Arteris price target by $3, citing updated assumptions around discount rates, revenue growth, profit margin, and future P/E that are reflected in the latest valuation model. Analyst Commentary Bearish analysts are treating the higher Arteris price target as a balance between long term potential and near term execution risk.
Actualización de narrativa Apr 05

AIP: AI Era Chip Adoption Will Support Continued Fair Value Upside

Analysts kept their Arteris fair value estimate steady at $24.00, and modest tweaks to assumptions around discount rate, revenue growth, profit margin and future P/E underpin a slightly refined but unchanged price target view. Analyst Commentary Recent Street research on Arteris points to a cluster of optimistic views, with bullish analysts adjusting price targets and sharpening their focus on the company’s execution and growth potential.
Actualización de narrativa Mar 21

AIP: AI Era Chip Demand And Execution Risks Will Shape Balanced Outlook

Analysts have lifted their price target on Arteris to $16.00 from $15.00, citing updated views on revenue growth, profit margins, and future P/E expectations. Analyst Commentary While the latest price target move reflects a more constructive view on Arteris, some bearish analysts are still flagging risks around execution and how the market is pricing the stock.
Actualización de narrativa Mar 07

AIP: AI Era Chip Adoption Will Drive Stronger Prospects Ahead

Analysts have raised their price target on Arteris from $16.00 to $24.00, citing updated assumptions around revenue growth, profitability, discount rates and future P/E that they believe better reflect the company’s prospects. Analyst Commentary Recent Street research around Arteris highlights a clear tilt toward more optimistic assumptions on the stock, as reflected in higher price targets that analysts view as better aligned with their updated models on revenue, profitability and valuation multiples.
Actualización de narrativa Feb 21

AIP: Index Addition And Expanding Design Wins Will Likely Support Upside

Analysts have raised their Arteris price target by $1 to $20.25, citing updates to revenue growth assumptions, profit margin outlook, discount rate inputs, and future P/E estimates reflected in recent Street research. Analyst Commentary Bullish Takeaways Bullish analysts highlight that the higher price target to $20.25 reflects refreshed assumptions on revenue growth and profitability, which they see as better aligned with recent Street modeling.
Actualización de narrativa Feb 07

AIP: Index Inclusion And AI IP Wins Will Support Balanced Outlook

Analysts are keeping their fair value estimate for Arteris steady at $15.00, pointing to small tweaks in assumptions around discount rates, revenue growth, profit margins, and future P/E that fine tune rather than materially shift their outlook. What's in the News Arteris, Inc.
Artículo de análisis Feb 04

Arteris, Inc.'s (NASDAQ:AIP) Intrinsic Value Is Potentially 25% Below Its Share Price

Key Insights Using the 2 Stage Free Cash Flow to Equity, Arteris fair value estimate is US$10.94 Arteris is estimated...
Actualización de narrativa Jan 24

AIP: Index Inclusion And New Design Wins Will Likely Unlock Upside

Analysts have raised their fair value estimate for Arteris from US$17.13 to US$19.25, citing updated assumptions on revenue growth, profit margins and future P/E that they view as better aligned with the company’s current risk profile. What's in the News Arteris, Inc.
Actualización de narrativa Jan 17

Arteris, Inc. (NASDAQ: AIP) – Acquisition of Cycuity Strengthens Position in Semiconductor Cybersecurity for the AI Era

Author: Qudus Adebara (Founder of Wane Investment House) Executive Summary Arteris, Inc. (“Arteris” or “the Company”), a leading provider of system IP for accelerating semiconductor development in the AI era, has closed its acquisition of Cycuity, Inc.
Actualización de narrativa Jan 09

AIP: Index Addition And AI IP Wins Will Mask Overvaluation Risk

Analysts maintained their fair value estimate for Arteris at $15.00, making only modest adjustments to assumptions on discount rate, revenue growth, profit margin, and future P/E to support this stable price target. What's in the News Arteris, Inc.
Actualización de narrativa Dec 25

AIP: Index Addition And AI Deals Will Support Balanced Long-Term Outlook

Analysts have raised their fair value estimate for Arteris from 11.00 dollars to 15.00 dollars, citing slightly stronger long term revenue growth expectations and an increased future earnings multiple, despite a modestly lower profit margin outlook. What's in the News Added to the S&P Software and Services Select Industry Index, increasing visibility among institutional investors (Index Constituent Adds).
Artículo de análisis Dec 12

Arteris, Inc. (NASDAQ:AIP) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected

Despite an already strong run, Arteris, Inc. ( NASDAQ:AIP ) shares have been powering on, with a gain of 27% in the...
Actualización de narrativa Dec 11

AIP: Expanded AI Wins Will Likely Fail To Justify Rich Expectations

Analysts have modestly raised their price target on Arteris to approximately $17.13 per share. This reflects slightly higher long term margin expectations and a marginally improved growth and risk profile.
Artículo de análisis Nov 29

Why Arteris, Inc. (NASDAQ:AIP) Could Be Worth Watching

While Arteris, Inc. ( NASDAQ:AIP ) might not have the largest market cap around , it led the NASDAQGM gainers with a...
Actualización de narrativa Nov 27

AIP: Major Platform Wins Will Drive Stronger Revenue And Margin Upside

Analysts have raised their price target for Arteris from $16.75 to $17.13, citing slight improvements in fair value estimates along with modest adjustments in discount rate and profit margin assumptions. What's in the News Blaize adopted Arteris' FlexNoC 5 interconnect IP to enhance the performance and scalability of its programmable AI platform, enabling better energy efficiency and faster time-to-market for edge and cloud AI applications (Client Announcements).
Actualización de narrativa Nov 12

AIP: Revenue Momentum And Client Wins Will Support Balanced Outlook

Analysts have raised their price target for Arteris from $15.00 to $16.75, citing improved revenue growth estimates and slight enhancements to profit margin expectations. What's in the News Blaize has adopted Arteris FlexNoC 5 interconnect IP to enhance the performance and scalability of its AI Platform for hybrid edge and cloud deployments (Client Announcements).
Artículo de análisis Nov 07

Arteris, Inc. (NASDAQ:AIP) Analysts Are Pretty Bullish On The Stock After Recent Results

Shareholders of Arteris, Inc. ( NASDAQ:AIP ) will be pleased this week, given that the stock price is up 12% to...
Actualización de narrativa Oct 29

Broader Partnerships And AI Adoption Will Shape Future Enterprise Demand

Analysts have raised their price target for Arteris by $1, from $14 to $15. They cited adjustments in growth and profitability expectations, despite a modest reduction in projected revenue growth and profit margins.
Artículo de análisis Oct 28

Revenues Not Telling The Story For Arteris, Inc. (NASDAQ:AIP) After Shares Rise 48%

Arteris, Inc. ( NASDAQ:AIP ) shareholders would be excited to see that the share price has had a great month, posting a...
Artículo de análisis Sep 05

Risks Still Elevated At These Prices As Arteris, Inc. (NASDAQ:AIP) Shares Dive 32%

The Arteris, Inc. ( NASDAQ:AIP ) share price has softened a substantial 32% over the previous 30 days, handing back...
Actualización de narrativa Aug 08

AI And Chiplet Trends Will Expand Enterprise Markets

With both the discount rate and future P/E multiples remaining virtually unchanged, Arteris’ consensus analyst price target also held steady at $14.00. What's in the News Arteris provided updated revenue guidance for Q3 2025 of $16.8–$17.2 million and full year 2025 of $66.0–$70.0 million.
Artículo de análisis Aug 06

Estimating The Intrinsic Value Of Arteris, Inc. (NASDAQ:AIP)

NasdaqGM:AIP 1 Year Share Price vs Fair Value Explore Arteris's Fair Values from the Community and select yours Key...
Artículo de análisis Jun 20

Is It Time To Consider Buying Arteris, Inc. (NASDAQ:AIP)?

Arteris, Inc. ( NASDAQ:AIP ), might not be a large cap stock, but it led the NASDAQGM gainers with a relatively large...
Artículo de análisis Jun 20

Revenues Not Telling The Story For Arteris, Inc. (NASDAQ:AIP) After Shares Rise 25%

Arteris, Inc. ( NASDAQ:AIP ) shares have had a really impressive month, gaining 25% after a shaky period beforehand...
Artículo de análisis May 15

Arteris, Inc. (NASDAQ:AIP) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Investors in Arteris, Inc. ( NASDAQ:AIP ) had a good week, as its shares rose 3.7% to close at US$7.51 following the...
Artículo de análisis Apr 19

Market Cool On Arteris, Inc.'s (NASDAQ:AIP) Revenues Pushing Shares 26% Lower

To the annoyance of some shareholders, Arteris, Inc. ( NASDAQ:AIP ) shares are down a considerable 26% in the last...
User avatar
Nueva narrativa Mar 28

Semiconductor IP And FlexGen Systems Will Expand AI Automotive Markets

Growing demand for AI and automotive solutions, alongside strategic microcontroller expansion, is set to drive Arteris' revenue and earnings growth.
Artículo de análisis Feb 26

Some Confidence Is Lacking In Arteris, Inc. (NASDAQ:AIP) As Shares Slide 26%

Arteris, Inc. ( NASDAQ:AIP ) shares have retraced a considerable 26% in the last month, reversing a fair amount of...
Seeking Alpha Feb 24

Arteris Q4: Long Growth Runway Ahead Overshadowed By The Lack Of Profitability

Summary Management has guided for 15% year over year ACV plus Royalties, with corresponding growth in RPO of 22%. While the company, Arteris, remains unprofitable, margins are projected to improve, with positive FCF expected in 2025. At 4.5 times ACV plus Royalties, its valuation represents a significant discount compared to larger peers. Given its higher risk profile, I recommend AIP stock as a speculative Buy. Read the full article on Seeking Alpha
Artículo de análisis Feb 21

Arteris, Inc. (NASDAQ:AIP) Analysts Are Pretty Bullish On The Stock After Recent Results

Arteris, Inc. ( NASDAQ:AIP ) came out with its full-year results last week, and we wanted to see how the business is...
Artículo de análisis Dec 28

Is Arteris (NASDAQ:AIP) Using Debt Sensibly?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Artículo de análisis Dec 01

Arteris, Inc. (NASDAQ:AIP) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

Arteris, Inc. ( NASDAQ:AIP ) shareholders would be excited to see that the share price has had a great month, posting a...
Seeking Alpha Oct 13

Arteris: Favorable Industry Trends Set To Fuel Growth Ahead

Summary The company is poised to benefit from industry tailwinds arising from AI and autonomous driving, owing to its strong technology offering. Growth is strong, with the business already generating positive FCF so far this year. I expect mid double-digit growth rates to continue in the coming years, with an inflection to non-GAAP profitability likely next year. While risks are significant, the appealing valuation leads me to rate the shares as a speculative Buy. Read the full article on Seeking Alpha
Artículo de análisis Jul 27

What Arteris, Inc.'s (NASDAQ:AIP) 26% Share Price Gain Is Not Telling You

Despite an already strong run, Arteris, Inc. ( NASDAQ:AIP ) shares have been powering on, with a gain of 26% in the...
Artículo de análisis May 07

Revenues Not Telling The Story For Arteris, Inc. (NASDAQ:AIP) After Shares Rise 32%

Arteris, Inc. ( NASDAQ:AIP ) shares have continued their recent momentum with a 32% gain in the last month alone. The...
Artículo de análisis Feb 09

Optimistic Investors Push Arteris, Inc. (NASDAQ:AIP) Shares Up 29% But Growth Is Lacking

Despite an already strong run, Arteris, Inc. ( NASDAQ:AIP ) shares have been powering on, with a gain of 29% in the...
Artículo de análisis Dec 14

Subdued Growth No Barrier To Arteris, Inc. (NASDAQ:AIP) With Shares Advancing 39%

Arteris, Inc. ( NASDAQ:AIP ) shareholders are no doubt pleased to see that the share price has bounced 39% in the last...
Artículo de análisis Nov 09

Downgrade: Here's How Analysts See Arteris, Inc. (NASDAQ:AIP) Performing In The Near Term

One thing we could say about the analysts on Arteris, Inc. ( NASDAQ:AIP ) - they aren't optimistic, having just made a...

Previsiones de crecimiento de beneficios e ingresos

NasdaqGM:AIP - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
FechaIngresosBeneficiosFlujo de caja libreFlujo de caja operativoNúm. de analistas medio
12/31/20281528N/AN/A2
12/31/2027113-20N/A144
12/31/202694-31N/A04
3/31/202677-35-5-3N/A
12/31/202571-3557N/A
9/30/202566-3401N/A
6/30/202563-33-2-1N/A
3/31/202561-3212N/A
12/31/202458-34-1-1N/A
9/30/202455-36-2-1N/A
6/30/202453-36-6-5N/A
3/31/202453-37-8-7N/A
12/31/202354-37-17-16N/A
9/30/202352-34-15-13N/A
6/30/202352-33-17-16N/A
3/31/202352-30-15-14N/A
12/31/202250-27-8-7N/A
9/30/202251-28-4-3N/A
6/30/202247-25-10N/A
3/31/202243-23-4-3N/A
12/31/202138-23-2-1N/A
9/30/202141-8-2-1N/A
6/30/202138-700N/A
3/31/202133-622N/A
12/31/202032-322N/A
12/31/2019325N/A12N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Se prevé que AIP siga sin ser rentable en los próximos 3 años.

Beneficios vs. Mercado: Se prevé que AIP siga sin ser rentable en los próximos 3 años.

Beneficios de alto crecimiento: Se prevé que AIP siga sin ser rentable en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos (23.2% al año) de AIP crezcan más rápidamente que los del mercado US (11.8% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos (23.2% al año) de AIP crezcan más rápidamente que un 20% al año.


Previsiones de crecimiento de los beneficios por acción


Rentabilidad financiera futura

ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de AIP se prevé que sea elevada dentro de 3 años.


Descubre empresas en crecimiento

Análisis de la empresa y estado de los datos financieros

DatosÚltima actualización (huso horario UTC)
Análisis de la empresa2026/06/08 20:18
Precio de las acciones al final del día2026/06/05 00:00
Beneficios2026/03/31
Ingresos anuales2025/12/31

Fuentes de datos

Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.

PaqueteDatosMarco temporalEjemplo Fuente EE.UU. *
Finanzas de la empresa10 años
  • Cuenta de resultados
  • Estado de tesorería
  • Balance
Estimaciones del consenso de analistas+3 años
  • Previsiones financieras
  • Objetivos de precios de los analistas
Precios de mercado30 años
  • Precios de las acciones
  • Dividendos, escisiones y acciones
Propiedad10 años
  • Accionistas principales
  • Información privilegiada
Gestión10 años
  • Equipo directivo
  • Consejo de Administración
Principales avances10 años
  • Anuncios de empresas

* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.

A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.

Modelo de análisis y copo de nieve

Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.

Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.

Métricas industriales y sectoriales

Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.

Fuentes analistas

Arteris, Inc. está cubierta por 6 analistas. 4 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.

AnalistaInstitución
Ambrish SrivastavaBMO Capital Markets Equity Research
Blayne CurtisJefferies LLC
Mark LipacisJefferies LLC